Adient PLC
NYSE:ADNT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adient PLC
NYSE:ADNT
|
IE |
|
T
|
Thyrocare Technologies Ltd
BSE:539871
|
IN |
|
Bausch Health Companies Inc
TSX:BHC
|
CA |
|
L
|
Learnd SE
XETRA:LRND
|
LU |
|
Alignment Healthcare LLC
NASDAQ:ALHC
|
US |
|
A
|
Accredited Solutions Inc
OTC:ASII
|
US |
|
Shree Cement Ltd
BSE:500387
|
IN |
|
Technical Publications Service SpA
MIL:TPS
|
IT |
|
E
|
Entra ASA
OSE:ENTRA
|
NO |
|
Suruga Bank Ltd
TSE:8358
|
JP |
|
Hindustan Copper Ltd
NSE:HINDCOPPER
|
IN |
|
Adyen NV
OTC:ADYEY
|
NL |
|
Omega Diagnostics Group PLC
LSE:ODX
|
UK |
|
ACI Worldwide Inc
NASDAQ:ACIW
|
US |
Wall St Price Targets
ADNT Price Targets Summary
Adient PLC
According to Wall Street analysts, the average 1-year price target for
ADNT is 30.98 USD with a low forecast of 22.22 USD and a high forecast of 54.72 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADNT's stock price target?
Price Target
30.98
USD
According to Wall Street analysts, the average 1-year price target for
ADNT is 30.98 USD with a low forecast of 22.22 USD and a high forecast of 54.72 USD.
What is the Revenue forecast for Adient PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 5 years is 3%.
What is the Operating Income forecast for Adient PLC?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 5 years is 14%.